These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8299652)

  • 1. Usefulness of technetium-99m hydroxymethylene diphosphonate scans in localizing bone metastases of differentiated thyroid carcinoma.
    Tenenbaum F; Schlumberger M; Bonnin F; Lumbroso J; Aubert B; Benali H; Parmentier C
    Eur J Nucl Med; 1993 Dec; 20(12):1168-74. PubMed ID: 8299652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
    Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
    J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
    Unal S; Menda Y; Adalet I; Boztepe H; Ozbey N; Alagöl F; Cantez S
    J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.
    Kosuda S; Yokoyama H; Katayama M; Yokokawa T; Kusano S; Yamamoto O
    Eur J Nucl Med; 1995 Oct; 22(10):1218-20. PubMed ID: 8542909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of (99m)Tc-MIBI for detecting bone marrow metastases.
    Wakasugi S; Noguti A; Katuda T; Hashizume T; Hasegawa Y
    J Nucl Med; 2002 May; 43(5):596-602. PubMed ID: 11994520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
    Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
    J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation.
    Dadparvar S; Chevres A; Tulchinsky M; Krishna-Badrinath L; Khan AS; Slizofski WJ
    Eur J Nucl Med; 1995 Nov; 22(11):1330-8. PubMed ID: 8575487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma.
    Miyamoto S; Kasagi K; Misaki T; Alam MS; Konishi J
    J Nucl Med; 1997 Mar; 38(3):352-6. PubMed ID: 9074516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Ng DC; Sundram FX; Sin AE
    J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical approach in patients with metastatic differentiated thyroid carcinoma and negative 131I whole body scintigraphy: importance of 99mTc MIBI scan combined with high resolution neck ultrasonography.
    Casara D; Rubello D; Saladini G; Mazzarotto R; Sotti G; Tomasella G; Pelizzo MR
    Tumori; 1999; 85(2):122-7. PubMed ID: 10363078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?
    Fatourechi V; Hay ID; Mullan BP; Wiseman GA; Eghbali-Fatourechi GZ; Thorson LM; Gorman CA
    Thyroid; 2000 Jul; 10(7):573-7. PubMed ID: 10958309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection and localization of multiple metastases from differentiated thyroid carcinoma with 99mTc-MIBI whole body scintigraphy: a case report].
    Kosuda S; Arai S; Soya T; Toshima H; Kusano S
    Kaku Igaku; 1994 Oct; 31(10):1243-8. PubMed ID: 7807728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic scintigraphy and effectiveness of 131I radioiodine therapy in differentiated thyroid carcinoma (DTC)].
    Bałdys-Waligórska A; Buziak-Bereza M; Huszno B; Wilczak A
    Endokrynol Pol; 2006; 57(4):380-5. PubMed ID: 17006840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
    Filesi M; Signore A; Ventroni G; Melacrinis FF; Ronga G
    J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location of functioning metastases from differentiated thyroid carcinoma by simultaneous double isotope acquisition of I-131 whole body scan and bone scan.
    Ceccarelli C; Bianchi F; Trippi D; Brozzi F; Di Martino F; Santini P; Elisei R; Pinchera A
    J Endocrinol Invest; 2004 Oct; 27(9):866-9. PubMed ID: 15648552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.